Involvement of Inflammation and Its Resolution in Disease and Therapeutics
Open Access
- 14 September 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (18) , 10719
Abstract
Inflammation plays a critical role in the response to and survival from injuries and/or infections. It occurs in two phases: initiation and resolution; however, when these events do not resolve and persist over time, the inflammatory response becomes chronic, prompting diseases that affect several systems and organs, such as the vasculature and the skin. Here, we reviewed inflammation that occurs in selected infectious and sterile pathologies. Thus, the immune processes induced by bacterial sepsis as well as T. cruzi and SARS-CoV-2 infections are shown. In addition, vaccine adjuvants as well as atherosclerosis are revised as examples of sterile-mediated inflammation. An example of the consequences of a lack of inflammation resolution is given through the revision of wound healing and chronic wounds. Then, we revised the resolution of the latter through advanced therapies represented by cell therapy and tissue engineering approaches, showing how they contribute to control chronic inflammation and therefore wound healing. Finally, new pharmacological insights into the management of chronic inflammation addressing the resolution of inflammation based on pro-resolving mediators, such as lipoxin, maresin, and resolvins, examining their biosynthesis, biological properties, and pharmacokinetic and pharmaceuticals limitations, are given. We conclude that resolution pharmacology and advanced therapies are promising tools to restore the inflammation homeostasis.Keywords
Funding Information
- Chilean Government (11201312, 3220470, ID19I10028)
- FONDECYT (11201312, 3220470, ID19I10028)
- FONDEF (11201312, 3220470, ID19I10028)
This publication has 168 references indexed in Scilit:
- Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls painThe FASEB Journal, 2012
- Resolvins and Protectins in Inflammation ResolutionChemical Reviews, 2011
- Sterile inflammation: sensing and reacting to damageNature Reviews Immunology, 2010
- Human Gingiva-Derived Mesenchymal Stem Cells Elicit Polarization of M2 Macrophages and Enhance Cutaneous Wound HealingStem Cells, 2010
- Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsisNature, 2009
- Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regenerationJournal of The Royal Society Interface, 2006
- Cytokine Expression Patterns Associated with Systemic Adverse Events following Smallpox ImmunizationThe Journal of Infectious Diseases, 2006
- Pathogen Recognition and Innate ImmunityCell, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Resolution of inflammation: the beginning programs the endNature Immunology, 2005